PercP Anti-Human CD45 Antibody[HI30]

The PERCP Anti-Human CD45 Antibody [HI30] is a highly reliable and efficient tool for immunophenotyping and flow cytometry applications. This antibody specifically targets the CD45 antigen, a transmembrane glycoprotein expressed on all nucleated cells of hematopoietic origin. With its exceptional specificity and sensitivity, this antibody enables accurate identification and characterization of leukocyte populations in various biological samples.

The PERCP Anti-Human CD45 Antibody [HI30] is conjugated with Peridinin-chlorophyll-protein complex (PERCP), a bright and photostable fluorochrome. This conjugation enhances the signal intensity and allows for multi-color staining experiments, facilitating the simultaneous detection of multiple antigens. The PERCP fluorochrome emits in the green spectrum, making it compatible with commonly used flow cytometry instruments.

This antibody has been extensively validated and optimized to ensure consistent and reproducible results. It exhibits minimal non-specific binding and low background noise, enabling precise discrimination of positive and negative cell populations. Its high affinity and robust performance make it an ideal choice for research studies, clinical diagnostics, and therapeutic development.

The PERCP Anti-Human CD45 Antibody [HI30] is supplied in a convenient and ready-to-use format, eliminating the need for additional reagents or preparation steps. It is provided in a liquid formulation, ensuring ease of use and minimizing the risk of errors. Each batch of this antibody undergoes rigorous quality control procedures to guarantee its performance and reliability.

In summary, the PERCP Anti-Human CD45 Antibody [HI30] is a superior reagent for immunophenotyping and flow cytometry applications. Its exceptional specificity, sensitivity, and compatibility with multi-color staining experiments make it an invaluable tool for researchers and clinicians alike. Trust in the reliability and accuracy of this antibody to advance your scientific endeavors and contribute to the understanding and treatment of hematopoietic disorders.